Kurma Partners logo

Kurma Partners

Europe, Ile-de-France, France, Paris

Description

Kurma Partners is a management company specializing in the financing of innovation in healthcare and biotechnology.

Investor Profile

Kurma Partners has made 113 investments, with 10 in the past 12 months and 50% as lead.

Stage Focus

  • Series A (29%)
  • Seed (21%)
  • Series B (21%)
  • Series Unknown (12%)
  • Series C (7%)
  • Series D (3%)
  • Post Ipo Equity (3%)
  • Series E (1%)
  • Debt Financing (1%)
  • Convertible Note (1%)

Country Focus

  • France (59%)
  • The Netherlands (13%)
  • Spain (6%)
  • Sweden (4%)
  • Switzerland (4%)
  • Denmark (4%)
  • Belgium (4%)
  • Germany (3%)
  • Ireland (1%)
  • United States (1%)

Industry Focus

  • Health Care
  • Biotechnology
  • Pharmaceutical
  • Medical
  • Therapeutics
  • Medical Device
  • Life Science
  • Health Diagnostics
  • Genetics
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Kurma Partners frequently co-invest with?

Ysios Capital
Europe, Pais Vasco, Spain, San Sebastian
Co-Investments: 13
PS
North America, California, United States, San Francisco
Co-Investments: 9
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 9
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 21
BNP Paribas Développement
Europe, Ile-de-France, France, Paris
Co-Investments: 12
Eurazeo
Europe, Ile-de-France, France, Paris
Co-Investments: 9
Idinvest Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 52
Bpifrance
Europe, Ile-de-France, France, Maisons-alfort
Co-Investments: 23
Pontifax
Asia, Tel Aviv, Israel, Herzliya
Co-Investments: 11
Sunstone Life Science Ventures
Europe, Hovedstaden, Denmark, Copenhagen
Co-Investments: 7

Which angels does Kurma Partners often collaborate with?

CS
Europe, Ile-de-France, France, Paris
Shared Deals: 1

What are some of recent deals done by Kurma Partners?

Germitec SAS

Ivry-sur-seine, Ile-de-France, France

Germitec is a healthcare company that designs, Commercialize UV-C disinfection systems for hospital hygiene system.

Health CareMedical
Series BFeb 12, 2025
Amount Raised: $30,043,719
Hopia

Paris, Ile-de-France, France

Optimized resource planning solution for healthcare institutions

Health CareHospital
SeedJan 28, 2025
Amount Raised: $3,651,059
Coave Therapeutics

Paris, Ile-de-France, France

Horama develops gene therapies for rare inherited ocular and CNS (central nervous system) diseases.

BiotechnologyGeneticsLife ScienceNeuroscience
Series AJan 9, 2025
Amount Raised: $32,948,556
Omnidoc

Paris, Ile-de-France, France

Omnidoc is a tele-expertise platform for healthcare professionals to exchange medical opinions.

CollaborationHealth CareMedical
Series UnknownDec 3, 2024
Amount Raised: $6,305,700

Radiology augmented GPT to tackle the complexity of precision medicine

Artificial Intelligence (AI)Clinical TrialsComputer VisionHealth CareMachine LearningPharmaceuticalPrecision Medicine
SeedNov 28, 2024
Amount Raised: $16,896,405
PanTera

Mol, Antwerpen, Belgium

PanTera produces actinium-225 for personalized cancer treatment and radiopharmaceuticals.

Health CareManufacturingPharmaceutical
Series ASep 11, 2024
Amount Raised: $110,323,384
Spotlight Medical

Paris, Ile-de-France, France

Spotlight Medical develops AI tests to revolutionize cancer treatment, providing everyone with the best possible chance to beat cancer.

Artificial Intelligence (AI)BiotechnologyHealth CareMedicalPrecision Medicine
SeedJul 12, 2024
Amount Raised: $6,736,333
SciRhom

Martinsried, Bayern, Germany

SciRhom is a biotech enterprise that translate advanced scientific findings into game-changing therapies for autoimmune diseases.

BiotechnologyHealth Care
Series AJul 9, 2024
Amount Raised: $68,190,674
Vico Therapeutics

Leiden, Zuid-Holland, The Netherlands

Vico Therapeutics is a developer of ribonucleic acid (RNA) modulating therapies.

Health CareMedicalPharmaceutical
Series BJun 24, 2024
Amount Raised: $12,298,137
Memo Therapeutics

Schlieren, Zurich, Switzerland

Memo Therapeutics is an innovator in the field of antibody discovery and immune repertoire analysis.

BiotechnologyCollaboration
Series CMay 7, 2024
Amount Raised: $22,015,012